No Racial Difference in Recurrence-Free Survival in HR+, HER

Race demonstrated differences in overall survival outcomes, but not for three-year recurrence-free survival in patients with HR-positive, HER2-negative breast cancer, according to data.

Related Keywords

Tennessee , United States , San Antonio , Texas , Vanderbilt University , Sonya Reid , Vanderbilt University Medical Center , , Antonio Breast Cancer , Thenew England Journal , Basal Type , Clinical Oncology , Breast Cancer , Conference , News ,